Spironolactone lowers oil by blocking androgen receptors in sebaceous glands, the small oil glands, and it improves persistent adult female acne. Benefits build over weeks, side effects include menstrual changes and dizziness, and follow-up centers on pregnancy prevention and selective potassium testing. It is FDA-approved only for heart failure, hypertension and edema and is used off-label for adult female acne. The American Academy of Dermatology gave a conditional 2024 recommendation for this use, as described in the hybrid systematic review in the American Journal of Clinical Dermatology hybrid review.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How well does it work?
- What dose and timeline should you expect?
- What are the common side effects?
- Who needs potassium testing?
- Who should avoid it in pregnancy?
How well does it work?
In the SAFA phase-3 trial, 410 adult women with persistent facial acne took 50 mg daily rising to 100 mg daily. The Links Medicus summary of the trial reports significantly better Acne-QoL symptom scores than placebo, with benefit widening from week 12 to week 24 SAFA trial summary.
The FASCE multicenter double-blind trial enrolled 133 adult women with moderate acne. Inserm/FASCE investigators found spironolactone significantly more effective than doxycycline and very well tolerated. The result supports it as an alternative to cycline antibiotics for suitable women.
What dose and timeline should you expect?
Dermatologists often start 50 mg daily and raise the dose to 100-200 mg daily based on response. That titration approach comes from recent family-physician guidance for acne care.
Visible change takes time, often weeks to 3 months. Doctors often add combined oral contraception to reduce menstrual irregularity, the most frequent side effect.
What are the common side effects?
FDA-approved labeling lists menstrual irregularity, breast tenderness, headache, dizziness, nausea, urinary frequency and low blood pressure. Most of these are mild but can affect daily life.
Use in men is limited by breast enlargement and reduced libido. Gynecomastia, or male breast enlargement, is the most common labeled reaction in men.
Who needs potassium testing?
A JAMA Dermatology study of 974 otherwise healthy young women found hyperkalemia, or high potassium, in 0.72% during treatment versus 0.76% at baseline. That rate matches the general population, so routine checks have low value in this group.
The practical approach is targeted testing, as summarized in the Cutis practical review of AAD guidance practical review of AAD guidance. Ask your prescriber which group fits you:.
- older age, kidney disease, other illness, or drugs that raise potassium — test 1-2 weeks after starting or raising the dose
- healthy and without those factors — no routine potassium test
- high potassium or Addison disease — do not use spironolactone
Who should avoid it in pregnancy?
Avoid spironolactone in pregnancy because of risk of feminization of a male fetus. Use reliable contraception during treatment and discuss pregnancy plans before starting.
Long-term cancer data are reassuring. The 2025 Dermatology and Therapy review found no increased breast or other cancer risk in large cohorts, including 101,502 women with acne, plus a seven-study meta-analysis 2025 Dermatology and Therapy review. Tell your prescriber right away if you suspect pregnancy while taking it.